Bridgeway Capital Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-74,000
| Closed | -$40.2K | – | 1331 |
|
|
2024
Q2 | $40.2K | Hold |
74,000
| – | – | ﹤0.01% | 1234 |
|
|
2024
Q1 | $75.5K | Hold |
74,000
| – | – | ﹤0.01% | 1240 |
|
|
2023
Q4 | $42.2K | Hold |
74,000
| – | – | ﹤0.01% | 1325 |
|
|
2023
Q3 | $77K | Sell |
74,000
-51,000
| -41% | -$53K | ﹤0.01% | 1262 |
|
|
2023
Q2 | $176K | Hold |
125,000
| – | – | ﹤0.01% | 1165 |
|
|
2023
Q1 | $199K | Hold |
125,000
| – | – | 0.01% | 1107 |
|
|
2022
Q4 | $183K | Buy |
125,000
+30,000
| +32% | +$43.8K | ﹤0.01% | 1105 |
|
|
2022
Q3 | $406K | Buy |
95,000
+25,000
| +36% | +$107K | 0.01% | 947 |
|
|
2022
Q2 | $272K | Hold |
70,000
| – | – | 0.01% | 1017 |
|
|
2022
Q1 | $333K | Buy |
70,000
+35,000
| +100% | +$167K | 0.01% | 1045 |
|
|
2021
Q4 | $128K | Sell |
35,000
-15,000
| -30% | -$54.9K | ﹤0.01% | 1203 |
|
|
2021
Q3 | $401K | Hold |
50,000
| – | – | 0.01% | 1097 |
|
|
2021
Q2 | $567K | Buy |
+50,000
| New | +$567K | 0.01% | 1027 |
|